메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
문상원 (인제대학교) 박신형 (순천향대학교) Oh Minkyung (Clinical Trial Center Busan Paik Hospital Inje University College of Medicine) 왕준호 (삼성서울병원)
저널정보
대한슬관절학회 Knee Surgery and Related Research Knee Surgery and Related Research 제33권
발행연도
2021.12
수록면
32 - 32 (1page)
DOI
10.1186/s43019-021-00104-4

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
The study investigated whether allogeneic human umbilical cord blood-derived MSCs (hUCB-MSCs) could be safely used without treatment-related adverse events, reducing tunnel enlargement, and improve clinical results in human anterior cruciate ligament (ACL) reconstruction.Thirty patients were enrolled consecutively. They were divided into three groups by randomization. In the negative control group, ACL reconstruction surgery without additional treatment was performed. In the experimental group, a hUCB-MSC and hyaluronic acid mixture was applied to the tendon-bone interface of the femoral tunnels during ACL reconstruction surgery. In the positive control group, only hyaluronic acid was applied. Finally, 27 patients were analyzed after the exclusion of three patients. The incidence of treatment-related adverse events, clinical outcomes, including second-look arthroscopic findings, and the amount of tunnel enlargement, were evaluated. There were no treatment-related adverse events in the treatment groups. Tunnel enlargement in the experimental group (579.74?±?389.85?mm 3 ) was not significantly different from those in the negative (641.97?±?455.84?mm 3 ) and positive control (421.96?±?274.83?mm 3 ) groups ( p =?0.6468). There were no significant differences between the groups in clinical outcomes such as KT-2000 measurement ( p =?0.793), pivot shift test ( p =?0.9245), International Knee Documentation Committee subjective score ( p =?0.9195), Tegner activity level ( p =?0.9927), and second-look arthroscopic findings (synovial coverage of the graft, p =?0.7984; condition of the graft, p =?0.8402). Allogeneic hUCB-MSCs were used safely for ACL reconstruction without treatment-related adverse event in a 2-year follow-up. However, our study did not suggest any evidence to show clinical advantage such as the prevention of tunnel enlargement postoperatively and a decrease in knee laxity or improvement of clinical outcomes. CRIS, Registration Number: KCT0000917. Registered on 12 November 2013; https://cris.nih.go.kr/cris/index.jsp

목차

등록된 정보가 없습니다.

참고문헌 (0)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0